Table S1. A summary of the isolates with their epidemiological and meta-data. (XLSX 22 kb
Table S1. Inpatient tracking within de hospital. X-axis corresponds to the days of month, starting f...
Figure S1. Percentage distribution of hospital-acquired infection (HA), and community-acquired infec...
Percentage of similarity between the outbreak isolates and the reference sequence of ST80/CT104 line...
Table detailing the accession numbers of isolates used within the study. (XLSX 13 kb
Table S1. Amino acid identities of vanB gene cluster of wild M1 and Y7 strains. aThe genetic informa...
Figure S2. Molecular typing of VREfm isolates. PCR amplification of the most frequently found clonal...
Table S2. Mutations in intracytoplasmic domain of VanSB and glycopeptides MICs of the VAN-resistant ...
Figure S1. Amino acid sequence alignment of VanSB encoded by M1/Y7 and the other VanB-type VRE. The ...
Figure S4. PFGE of S1 nuclease-treated DNA and hybridization with vanB gene probes. PFGE of S1 nucle...
Figure S1. VREfm outbreak response and incident management. The Figure shows the departments involve...
Table S3. Oligonucleotides used in this study. aSmall letters indicate additional tag-nucleotides fo...
Additional file 1. Accession number and information on publicly available isolates
Figure S5. PFGE of I-CeuI-digested DNA and hybridization with 23srRNA gene and vanB gene probes. PFG...
Figure S3. Amino acid sequence alignment of VanW encoded by M1/Y7 and the other VanB-type VRE. The g...
Figure S3. Epidemiological curve depicting VREfm acquisition according to patient location by wards....
Table S1. Inpatient tracking within de hospital. X-axis corresponds to the days of month, starting f...
Figure S1. Percentage distribution of hospital-acquired infection (HA), and community-acquired infec...
Percentage of similarity between the outbreak isolates and the reference sequence of ST80/CT104 line...
Table detailing the accession numbers of isolates used within the study. (XLSX 13 kb
Table S1. Amino acid identities of vanB gene cluster of wild M1 and Y7 strains. aThe genetic informa...
Figure S2. Molecular typing of VREfm isolates. PCR amplification of the most frequently found clonal...
Table S2. Mutations in intracytoplasmic domain of VanSB and glycopeptides MICs of the VAN-resistant ...
Figure S1. Amino acid sequence alignment of VanSB encoded by M1/Y7 and the other VanB-type VRE. The ...
Figure S4. PFGE of S1 nuclease-treated DNA and hybridization with vanB gene probes. PFGE of S1 nucle...
Figure S1. VREfm outbreak response and incident management. The Figure shows the departments involve...
Table S3. Oligonucleotides used in this study. aSmall letters indicate additional tag-nucleotides fo...
Additional file 1. Accession number and information on publicly available isolates
Figure S5. PFGE of I-CeuI-digested DNA and hybridization with 23srRNA gene and vanB gene probes. PFG...
Figure S3. Amino acid sequence alignment of VanW encoded by M1/Y7 and the other VanB-type VRE. The g...
Figure S3. Epidemiological curve depicting VREfm acquisition according to patient location by wards....
Table S1. Inpatient tracking within de hospital. X-axis corresponds to the days of month, starting f...
Figure S1. Percentage distribution of hospital-acquired infection (HA), and community-acquired infec...
Percentage of similarity between the outbreak isolates and the reference sequence of ST80/CT104 line...